⌘K

Login Start Free

Home/Filings/4/0001237899-13-000050

4//SEC Filing

REGENERON PHARMACEUTICALS INC 4

Accession 0001237899-13-000050

$REGNCIK 0000872589operating

View on SEC.gov Company Profile

Filed

Sep 19, 8:00 PM ET

Accepted

Sep 20, 4:24 PM ET

Size

15.0 KB

Accession

0001237899-13-000050

Insider Transaction Report

Form 4

Period: 2013-09-18

REGENERON PHARMACEUTICALS INCREGN

ROBERTS WILLIAM

VP Regul Devel & Clin Safety

Transactions

Sale
Common Stock
2013-09-18$304.00/sh−15,000$4,560,000→ 20,644 total
Gift
Common Stock
2013-09-19−4,000→ 16,644 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2013-09-18−15,000→ 9,048 total
Exercise: $16.80Exp: 2018-12-17→ Common Stock (15,000 underlying)
Gift
Common Stock
2013-06-13+4,000→ 20,644 total
Exercise/Conversion
Common Stock
2013-09-18$16.80/sh+15,000$252,000→ 35,644 total
Gift
Common Stock
2013-06-13−4,000→ 13,447 total(indirect: By Spouse)

Holdings

Common Stock
(indirect: by GRAT)
17,000
Common Stock
(indirect: By Trust)
1,200
Common Stock
(indirect: By 401(k))
4,388
Common Stock
(indirect: By Trust)
1,200

Footnotes (3)

[F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
[F2]Gift of Common Stock to a charitable foundation.
[F3]The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

REGENERON PHARMACEUTICALS INC

CIK 0000872589

Entity typeoperating

IncorporatedNY

Related Parties

1

filerCIK 0000872589

Filing Metadata

Form type: 4
Filed: Sep 19, 8:00 PM ET
Accepted: Sep 20, 4:24 PM ET
Size: 15.0 KB

View on SEC.gov